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Abstract
Background: Dendritic cells (DCs) are central to the initiation and regulation of the
adaptive immune response during infection. Modulation of DC function may therefore allow
evasion of the immune system by pathogens. Significant depression of the host’s systemic
immune response to both concurrent infections and heterologous vaccines has been
observed during malaria infection, but the mechanisms underlying this immune
hyporesponsiveness are controversial.
Results: Here, we demonstrate that the blood stages of malaria infection induce a failure of
DC function in vitro and  in vivo, causing suboptimal activation of T cells involved in
heterologous immune responses. This effect on T-cell activation can be transferred to
uninfected recipients by DCs isolated from infected mice. Significantly, T cells activated by
these DCs subsequently lack effector function, as demonstrated by a failure to migrate to
lymphoid-organ follicles, resulting in an absence of B-cell responses to heterologous antigens.
Fractionation studies show that hemozoin, rather than infected erythrocyte (red blood cell)
membranes, reproduces the effect of intact infected red blood cells on DCs. Furthermore,
hemozoin-containing DCs could be identified in T-cell areas of the spleen in vivo. 
Conclusions:  Plasmodium  infection inhibits the induction of adaptive immunity to
heterologous antigens by modulating DC function, providing a potential explanation for
epidemiological studies linking endemic malaria with secondary infections and reduced vaccine
efficacy.
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Malaria is the major parasitic disease of humans throughout
the tropics and subtropics, mainly affecting children under
5 years of age and causing 500 million clinical cases and up
to 2.7 million deaths each year [1]. In addition to infection-
induced mortality, malaria is also associated with public-
health problems resulting from impairment of immune
responses. Although this immunosuppression may have
evolved as a mechanism by which the parasite can prevent
immune-mediated clearance [2-8], it leaves malaria-infected
individuals or experimental animals more susceptible to
secondary infections, such as non-typhoidal Salmonella [9],
herpes zoster virus [10], hepatitis B virus [11], Moloney
leukemia virus [12] and nematode infection [13], as well as
Epstein-Barr virus reactivation [14-17]. Because the efficacy
of heterologous vaccines can also be suppressed in malaria-
infected patients [18-21], children showing clinical signs of
malaria are rarely immunized until after anti-malarial
chemoprophylaxis, which can improve the response to vac-
cination [22]. In a recent study of a new conjugate vaccine
against pneumococci, efficacy was reduced during the
malaria transmission season [23], demonstrating the possi-
ble impact of malaria infection on large-scale vaccine
regimes. Certain vaccines, however, seem to induce protec-
tive responses irrespective of malaria status and the
immunosuppressive effect of malaria infection might thus
not extend to all antigens [20]; studies in vivo are required to
investigate this controversy further. Several animal studies
have described suppression of immune function by Plas-
modium parasites in vitro and in vivo [24-34], but the mecha-
nisms involved remain unclear.
Dendritic cells (DCs) have a crucial role in the activation of
T cells and consequently in the induction of adaptive
immune responses and immunity [35,36]. There is evidence
that many pathogens have evolved mechanisms that subvert
DC function, thereby modulating the host’s immune
response to their advantage [37,38]. Recent studies have
revealed that DCs are important in malaria infection, partic-
ularly during the early events of induction of the protective
immune response to infection [39,40]. It has been reported
that red blood cells (RBCs) infected with schizont-stage
Plasmodium falciparum  activate plasmacytoid DCs as
detected by increased expression of the antigen CD86 and
the cytokine interferon- (IFN-) in vitro [41]. In contrast,
the asexual erythrocytic stages of P. falciparum were shown to
impair the ability of human DCs to undergo maturation in
vitro [42]. Indeed, peripheral blood DCs of P. falciparum-
infected children showed reduced levels of the major histo-
compatibility complex (MHC) molecule HLA-DR compared
with uninfected controls [43], suggesting a reduced activ-
ation state. Thus, the ability of malaria parasites to inhibit
maturation of DCs could be involved not only in parasite-
specific immunosuppression but also in the suppression of
responses to heterologous antigens such as vaccines and
unrelated pathogens [2,19,20]. As human malaria parasites
are host-specific, however, observations on the effect of
human malaria on DCs are largely limited to studies  in vitro. 
Here, we describe the mechanism underlying this suppres-
sion of immunity in vitro and  in vivo. DC activation is
dynamically altered by parasitized erythrocytes (pRBCs),
partly because of deposition of the malarial pigment hemo-
zoin (HZ) within these cells. Following presentation of het-
erologous antigen by pRBC-exposed DCs, there is less
expansion of CD4+ ‘helper’ T cells that are essential for the
induction of adaptive immunity. Subsequently, migration
of T cells to lymphoid follicles is abrogated, leading to
defective B-cell expansion and differentiation and a failure
of the antibody response. These studies explain why immu-
nity to malaria is slow to develop and why protection
against secondary infections is reduced in Plasmodium-
infected individuals.
Results 
Suppression of heterologous immune responses
during malaria infection 
We first examined the response to a heterologous antigen
during Plasmodium chabaudi (AS strain) infection (Figure 1a)
to determine whether this murine model reflected the clini-
cal immunosuppression observed with P. falciparum infec-
tion [18-21]. Mice were immunized with the model antigen
ovalbumin (OVA) and lipopolysaccharide (LPS) to act as
adjuvant at various times after infection, and OVA-specific
serum immunoglobulin G (IgG) was measured 21 days later.
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Figure 1 (see figure on the following page)
Suppression of immunity by P. chabaudi infection. (a) BALB/c mice were infected with 106 P. chabaudi (AS strain) parasites by intra-peritoneal
injection and the proportion of peripheral blood cells parasitized (parasitemia) was monitored by Giemsa’s stain of peripheral blood smears.
(b) Uninfected (squares) or P. chabaudi-infected (circles) BALB/c mice were immunized with OVA/LPS at the indicated times after infection. Three
weeks after immunization, sera were analyzed for OVA-specific IgG. Data represent the mean of three mice per group ±1 standard deviation (s.d.)
and are representative of two similar experiments (*p  0.05, #p  0.005 uninfected versus P. chabaudi-infected). (c) Spleen cells from uninfected
(open bars) or P. chabaudi-infected (filled bars) BALB/c mice immunized with OVA/LPS 10 days post-infection were re-stimulated in vitro as indicated
and supernatants assayed for levels of IFN- (left) and IL-5 (right) after 48 h. http://jbiol.com/content/5/2/5 Journal of Biology 2006, Volume 5, Article 5 Millington et al.  5.3
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Figure 1 (see legend on the previous page)
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(c)Uninfected, immunized animals generated OVA-specific IgG
responses, but OVA and LPS administered 6 hours and 12
days after infection with P. chabaudi produced significantly
reduced levels of IgG (Figure 1b). Interestingly, suppression
was lower in mice immunized during increasing levels of
parasite infection (parasitemia; Figure 1b, 4 days). By 21
days post-infection, infected animals had regained immune
responsiveness and mounted antibody responses of a similar
magnitude to those seen in uninfected controls (Figure 1b,
21 and 28 days). Production of OVA-stimulated and con-
canavalin A (ConA) mitogen-stimulated T-cell cytokines was
reduced in cultures of splenocytes taken from mice infected
with P. chabaudi 10 days before immunization (Figure 1c).
Thus, as described for P. falciparum in humans, P. chabaudi
infection in mice induces suppression of immune responses,
although these studies reveal that, in the animal model at
least, this is a highly dynamic phenomenon. 
Modulation of DCs in vitro by infected erythrocytes 
DC activation is central to induction of adaptive immunity
[35], and previous studies have suggested that several pro-
tozoan pathogens have evolved mechanisms to suppress this
response and consequently to reduce immune-mediated pro-
tection [44]. Human DCs cultured with P. falciparum-
infected erythrocytes are hyporesponsive to stimulation with
LPS and less capable of stimulating CD4+ T-cell responses
[42]. This observation remains controversial, however, as
studies using murine models have suggested that DCs may
be activated during increasing parasitemia in vivo [45] and
following culture in vitro with parasite schizont-infected
erythrocytes [40]. 
As the results above indicated that immune responsiveness
in vivo is dynamically regulated during infection, we studied
the ability of P. chabaudi-infected erythrocytes to modulate
DCs directly, by examining the expression of MHC class II
and co-stimulatory molecules on DCs. Bone-marrow-
derived DCs were incubated with infected erythrocytes and
the expression of surface markers examined at various times
over the following 24 hours. Our results show that DCs
expressed very low levels of surface MHC class II and the co-
stimulatory molecules CD40, CD80 and CD86 when cul-
tured in growth medium alone, thus confirming the
immature state of these DCs in culture (Figure 2a-d). Stimu-
lation with LPS promoted a significant increase in the
expression level of all co-stimulatory molecules within 6
hours. DCs incubated with RBCs or pRBCs did not,
however, increase expression of MHC class II, CD40, CD80
and CD86, indicating that malaria parasites do not induce
DC activation directly. Analysis of cytokine production
showed that DCs exposed to RBC or pRBCs produce small,
though detectable, amounts of both interleukins IL-12 and
IL-10 that are a thousand-fold lower than those observed
after LPS stimulation (Figure 2e,f), suggesting that the pres-
ence of parasites does not result in DC activation. The via-
bility of treated DCs and control cells was quantified after
24 hours of culture by trypan blue exclusion (Figure 2g) and
propidium iodide (PI) and annexin V staining (data not
shown) and was not significantly affected by pRBCs.
Having established that pRBCs at a ratio of 100:1 do not
directly induce DC maturation, we examined whether
pRBC-treated DCs retained their ability to mature in
response to LPS treatment in vitro. DCs were exposed to
RBCs or pRBCs for 24 hours and subsequently challenged
with LPS. After 18 hours of LPS stimulation, the expression
levels of MHC class II, CD40, CD80 and CD86 increased
significantly (Figure 3a-d). DCs pre-incubated with pRBCs
and subsequently challenged with LPS, however, showed
significantly lower levels of expression of MHC class II,
CD40, and CD86 compared with those observed when cells
were not treated with pRBCs or were pre-incubated with
RBCs before the LPS challenge (Figure 3a-d). Kinetic studies
demonstrated that the ability of pRBCs to induce this
hyporesponsive state in DCs required at least 6 hours pre-
incubation before the addition of LPS (data not shown).
Cytokine production following treatment with LPS showed
that, although DCs treated with pRBCs could still produce
appreciable levels of IL-12 and IL-10 in response to LPS,
the amount produced was significantly lower than that pro-
duced by DCs pre-incubated with RBCs (Figure 3e,f). As
the interaction between CD40 on DCs and its ligand
CD40L on T cells in vivo is known to be crucial in the pro-
duction of bioactive IL-12 and upregulation of adhesion
and co-stimulatory molecules [46,47], we stimulated bone-
marrow-derived DCs with CD40L-transfected fibroblasts
(Figure 3g,h). DCs treated with RBCs significantly upregu-
lated CD40 expression in response to CD40L and produced
high levels of the inducible IL-12p40 subunit. CD40 liga-
tion, however, did not rescue the reduced maturation of
DCs treated with pRBCs, although, as previously observed
with the LPS treatment, these cells still produced IL-12 p40
but to a lesser extent than the control groups. 
Modulation of DCs in vivo during malaria infection 
As our results suggested that malaria-infected erythrocytes
might modulate the responsiveness of DCs in vitro, we next
investigated the activation status of splenic DCs in vivo
during a time-course of infection with P. chabaudi. DCs iso-
lated from spleens of mice 4 days after infection showed a
moderately activated phenotype, as demonstrated by
increased expression of CD40 and CD80 (Figure 4a), con-
firming previous reports [45]. DCs isolated from infected
animals 12 and 20 days after infection, however, showed a
reduced level of activation, with lower levels of CD40,
CD80, CD86 and MHC class II molecules on their surface
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Whereas DCs from uninfected mice upregulated CD40,
CD80 and CD86 following LPS stimulation (Figure 4d-g),
DCs isolated from the spleens of P. chabaudi-infected mice
remained refractory to in vitro LPS-induced maturation, with
reduced levels of these molecules following stimulation.
Thus it seems that, in vivo, DCs are activated soon after
infection, and the level of activation on DCs is reduced
http://jbiol.com/content/5/2/5 Journal of Biology 2006, Volume 5, Article 5 Millington et al.  5.5
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Figure 2
P. chabaudi-infected erythrocytes do not activate DCs directly in vitro. DCs (2 x 106) were cultured with 2 x 108 infected erythrocytes (DC+pRBC;
filled circles) or with an equal number of uninfected erythrocytes (DC+RBC; empty circles). Control DCs remained unstimulated (DC; empty
squares) or were stimulated with 1 g/ml of LPS (DC+LPS; filled squares). Results show the mean fluorescence intensity of (a) MHC class II,
(b) CD40, (c) CD80, and (d) CD86, as determined by FACS analysis of gated CD11c+ cells at various times of co-culture. Supernatants were
analyzed for concentrations of (e) IL-12 (p40 subunit) and (f) IL-10 secreted by DCs after 24 h of incubation. (g) The number of viable DCs was
determined by trypan blue exclusion. Results show the mean value ± standard error (s.e.) of triplicate samples per group. 
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Figure 3
P. chabaudi-infected erythrocytes inhibit the LPS and CD40L-induced maturation of DCs. DCs were cultured with infected (pRBC) or uninfected
(RBC) erythrocytes for 24 h, as described in Figure 2, then treated with 1 g/ml of LPS for a further 18 h. (a-f) Results were analyzed as described
in Figure 2 (*p  0.05 pRBC versus RBC). (g,h) DCs (1 x 106) were cultured with 1 x 108 infected erythrocytes (pRBC) before stimulation with
CD40L-expressing fibroblasts (filled bars) or control fibroblasts (open bars) at a 1:1 ratio of fibroblasts:DCs. Untreated DCs (Con) and uninfected
erythrocyte-treated DCs (RBC) were used as controls. DCs were incubated with fibroblasts for a further 18 h before analyzing CD40 expression
and cytokine production. CD40 expression on DCs is shown as the mean fluorescent intensity on CD11c+ cells. IL-12 production is shown as the
mean optical density (OD) read at 450 nm. Results show the mean value ± s.e. of triplicate samples per group (*p  0.05 pRBC versus RBC).
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Figure 4
Modulation of DC activation in vivo during P. chabaudi infection. (a-c) Splenic CD11c+ DCs were isolated from P. chabaudi infected mice at various
times (filled bars) or from uninfected controls (open bars) and analyzed by flow cytometry for the indicated markers. Data are expressed as mean
fluorescence intensity relative to uninfected samples ±1 s.d. (*p  0.05 uninfected versus P. chabaudi-infected). (d-g) Splenic DCs from uninfected
(open bars) or P. chabaudi-infected (filled bars; 12 days post-infection) BALB/c mice were restimulated in vitro with LPS (1 g/ml) for 18 h before
analysis by flow cytometry for (d) MHC class II, (e) CD40, (f) CD80 and (g) CD86. Data are expressed as mean fluorescence intensity relative to
uninfected, unstimulated samples ±1 s.d. (*p  0.05, #p  0.005 uninfected versus P. chabaudi-infected for the same treatment).
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(b)following the peak of infection (days 12-20), and this
cannot be abrogated by microbial stimulation ex vivo. 
Identification of P. chabaudi components that induce
DC hyporesponsiveness 
As we had demonstrated that malaria infection modulates
key aspects of DC function, we wanted to examine the pos-
sible mechanisms involved. Initially, to determine whether
maturation of the parasite from the trophozoite stage to the
schizont stage in vitro or some metabolic process within the
pRBCs was required for induction of DC hyporesponsive-
ness, pRBCs were fixed with paraformaldehyde and incu-
bated with DCs for 24 hours before the addition of LPS
(Figure 5a-c). The expression levels of MHC class II, CD40
and CD86 were significantly reduced when DCs were co-
cultured with fixed pRBCs before LPS challenge, confirming
that trophozoite-infected erythrocytes downregulate DC
activation in response to LPS treatment and suggesting that
growth and maturation of the parasite into schizonts is not
required for suppression. In an attempt to understand the
mechanisms involved in the parasite-mediated modulation
of DC function, we investigated the role of selected parasite
components on the LPS-induced maturation of DCs. We
addressed this question initially by analyzing the effect that
parasite proteins expressed on the erythrocyte surface mem-
brane have on DC function. DCs were exposed to RBC
membranes (ghosts) isolated from infected or uninfected
erythrocytes. After 24 hours of culture, DCs were challenged
with LPS and the expression of co-stimulatory molecules
analyzed 18 hours later (Figure 5d,e). Our results clearly
show that ghosts isolated from pRBCs did not alter the
ability of DCs to respond to LPS treatment in vitro, as
observed by the levels of MHC class II and CD40, demon-
strating that proteins expressed on the surface membranes
of pRBCs are apparently not essential for the modulation of
DC function. 
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Figure 5
Identification of P. chabaudi components that inhibit LPS-induced DC maturation. (a-c) DCs (2 x 106) were treated for 24 h with uninfected RBC
(open bars) or infected RBC (pRBC; filled bars) that were untreated or fixed before stimulation with LPS (1 g/ml) for 18 h. DC activation was
characterized by analysis of (a) MHC class II, (b) CD40, and (c) CD86 expression on CD11c+ DC surfaces by FACS (*p  0.05 pRBC versus RBC,
+p  0.05 fixed pRBC versus fixed RBC). (d,e) DCs (5 x 105) were incubated with intact erythrocytes or RBC ghosts from uninfected (open bars)
or infected erythrocytes (filled bars), for 24 h before stimulation with LPS for 18 h. DC activation was characterized by analysis of (d) MHC class II
and (e) CD40 expression on the DC surface by FACS (*p  0.05 pRBC versus RBC).
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Figure 6
Deposition of HZ in DCs suppresses maturation. (a) HZ content in bone-marrow-derived DCs (In vitro), purified DCs (Ex vivo) and spleen sections
(In vivo) was visualized by light microscopy (top images) or by false-coloring malaria pigment viewed in bright-field image (red) and superimposing
over the fluorescent CD11c image (green). (b) CD11c+ DCs were analyzed for size and granularity by flow cytometry 12 days post-infection with
P. chabaudi or in uninfected controls. Data are expressed as the mean forward scatter or side scatter of triplicate samples ±1 s.d. (*p  0.05,
#p  0.005 uninfected versus P. chabaudi-infected). (c-e) 2 x 106 DCs were cultured with 1 M, 5 M, 10 M and 20 M of HZ. After 24 h, the
level of expression of (c) MHC class II, (d) CD40 and (e) CD86 on CD11c+ cells was determined by FACS analysis. (f-h) After 24 h culture with HZ,
1 g/ml LPS was added to DCs and the levels of (f) MHC class II, (g) CD40, and (h) CD86 were analyzed 18 h later by FACS. All results are shown
as the mean fluorescence intensity on CD11c+ DCs in triplicate samples ± s.e. (*p  0.05 HZ versus LPS).
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HemozoinHaving established that parasite proteins expressed on the
erythrocyte cell membrane are not responsible for the mod-
ulation of LPS-induced maturation of DCs in vitro, we
focused our attention on HZ, a by-product of hemoglobin
digestion. We observed that bone-marrow-derived DCs cul-
tured in vitro with infected erythrocytes accumulated intra-
cellular malarial pigment (Figure 6a). Flow cytometric
analysis of splenic DCs, identified by CD11c expression,
also demonstrated an increase in the size and granularity of
DCs during infection (Figure 6b), and DCs isolated ex vivo
as well as DCs in spleen sections showed conspicuous HZ
deposition (Figure 6a). 
In order to assess the role of HZ in the parasite-induced
modulation of DC function, we initially analyzed its ability
to activate DCs directly in vitro (Figure 6c-e). Even at the
highest dose (20 M), HZ did not induce DC maturation,
as the levels of MHC class II, CD40 and CD86 were the
same as the levels expressed by untreated controls. We then
examined whether HZ-treated DCs still responded to LPS
treatment  in vitro (Figure 6f-h). Our data clearly demon-
strate a dose-dependent inhibition of the LPS-induced mat-
uration of DCs by HZ, as seen by the reduced levels of MHC
class II, CD40 and CD86. Taken together, these results indi-
cate that HZ, rather than pRBC membranes, is a key factor
involved in the suppression of murine DC function in vitro
and in vivo. 
Failure of pRBC-treated DCs to induce T-cell
effector function 
The above experiments clearly implicated HZ-mediated sup-
pression of DC function in the failure of antibody production
and in the delayed acquisition of protective immunity seen
during malaria infection in vivo. To examine the functional
consequences of malaria on DC function directly, we exam-
ined the ability of affected DCs to activate naive, OVA-specific
T-cell receptor-transgenic T cells. These cells allow monitoring
of the antigen-specific CD4+ T-cell response as their antigen
specificity is known and they can be tracked using a clono-
typic antibody directed against their T-cell receptor. One of
the earliest cell-surface antigens expressed by T cells following
activation is CD69, which is detectable within an hour of
ligation of the T-cell receptor complex [48]. Interestingly,
there was no significant difference in the percentage of OVA-
specific T cells expressing CD69 between RBC-treated and
pRBC-treated groups (Figure 7a), showing that T cells inter-
acting with modulated DCs are equally activated. 
To investigate whether treatment of DCs with pRBCs could
alter the dynamics of the T-cell proliferative response, we
harvested the T cells at 48, 72, 96 and 120 hours of culture
(Figure 7b). The ability of pRBC-treated DCs to induce
T-cell proliferation was dramatically reduced compared to
the control group throughout the observation period (see
Figure 7b). Analysis of T-cell production of IL-2, IL-5, IL-10
and IFN- (Figure 7c-f) revealed that each cytokine was
downregulated in the pRBC-treated groups compared with
RBC-treated controls. The observed reduction in T-cell pro-
liferation and cytokine production could not be explained
by T-cell death, as similar levels of necrotic and apoptotic T
cells were detected in both conditions by FACS analysis of
propidium iodide and annexin staining (data not shown).
Thus, although DCs pre-treated with pRBCs in vitro can
induce initial activation of naive CD4+ T cells, causing upreg-
ulation of CD69, these T cells fail to proliferate effectively
and have a reduced ability to secrete effector cytokines. 
Suppression of T- and B-cell proliferation during
malaria infection 
To characterize fully the downstream effects of HZ-induced
DC hyporesponsiveness on heterologous immune respon-
siveness, we directly investigated antigen-specific T-cell
responses in vivo by transferring traceable OVA-specific CD4+
T cells into recipient mice [49]. This allows us to follow the
response of a small, but detectable, number of antigen-
specific CD4+ T cells during the induction of an adaptive
immune response. Cells were transferred into recipients fol-
lowing the initial peak of parasitemia (day 12 of infection)
and immunized 1 day later. In P. chabaudi-infected immu-
nized mice, OVA-specific CD4+ T cells underwent a similar
initial activation to that of antigen-specific T cells in unin-
fected mice, as estimated by upregulation of CD69 (Figure
8a) and increased size/blastogenesis (also an indicator of
activation; data not shown), confirming the in vitro observa-
tion (see Figure 7a). Antigen-specific CD4+ T cells in lymph
nodes and in spleen failed to expand to the same extent in
infected mice as in uninfected controls (Figure 8b), however,
partly because the antigen-specific CD4+ T cells made a
reduced number of divisions (Figure 8c). Interestingly, we
did not detect increased apoptosis (determined by annexin
staining) of OVA-specific T cells transferred into malaria-
infected individuals (data not shown).
One of the most significant components of CD4+ T-cell effec-
tor function is migration into primary lymphoid follicles to
interact with, and provide help for, antigen-specific B cells
[50]. To track the effect of malaria infection on these popula-
tions, we transferred B-cell-receptor transgenic B cells specific
for hen egg-white lysozyme (HEL) taken from the MD4 trans-
genic mouse, together with the OVA-specific DO11.10 T cells
and immunized with OVA coupled to HEL [51]. B-cell expan-
sion in uninfected animals peaked 5 days after immunization
(Figure 9a). Expansion of HEL-specific B cells was almost
completely ablated in P. chabaudi-infected animals immu-
nized with OVA-HEL/LPS (Figure 9a), however, suggesting a
defect in B-cell activation and/or T-cell help in infected mice.
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Figure 7
P. chabaudi-infected erythrocytes inhibit the ability of DCs to efficiently activate naive T cells in vitro. DCs (2 x 105) were treated with infected
(pRBC) or uninfected (RBC) erythrocytes for 24 h. DCs were then loaded with 5 mg/ml of OVA for 6 h. 5 x 105 untreated (Control), RBC or
pRBC-treated DCs and 5 x 105 DO11.10 lymph node cells were then co-cultured. (a) CD69 expression assessed on DO11.10 T cells 24 h later by
FACS analysis. Results are expressed as the percentage of antigen-specific cells expressing CD69 in cultures stimulated by OVA-pulsed DCs (filled
bars) or by DCs only (open bars). Results show the mean of triplicate samples ± s.e. (b) [3H]thymidine was added for the last 18 h of culture; c.p.m.,
counts per min. Results show mean proliferation of OVA-specific T cells after incubation with DCs treated with uninfected RBCs (open circles) or
pRBCs (filled circles) in triplicate samples ± s.e. The concentrations of (c) IL-2, (d) IL-5 (e) IL-10, and (f) IFN- secreted by OVA-specific T cells
after incubation with DCs treated with uninfected RBCs (open circles) or pRBCs (filled circles) were measured in supernatants harvested after 24,
48, and 72 h of culture. 
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Figure 8
Suppression of CD4+ T-cell expansion by P. chabaudi infection in vivo. (a) Uninfected (open bars) or P. chabaudi-infected (filled bars) BALB/c mice
received DO11.10 T cells and remained unimmunized or were immunized with OVA/LPS 12 days post-infection. Expression of CD69 on splenic
OVA-specific T cells was assessed 18 h post-immunization. Results shown are the proportion of OVA-specific CD4+KJ1.26+ T cells expressing CD69
and represent the mean of three mice per group ±1 s.d. (b) Uninfected (squares) or P. chabaudi-infected (circles) BALB/c mice were transferred and
immunized (filled symbols) or remained unimmunized (open symbols) and the absolute number of OVA-specific T cells in spleen (left) and lymph
nodes (right) calculated at various times. Results show the mean number of CD4+KJ1.26+ T cells and represent the mean of three mice per group 
±1 s.d. (*p  0.05, #p  0.005 uninfected and immunized versus P. chabaudi-infected and immunized). (c) Representative CFSE profiles of OVA-
specific T cells are shown (left) and data shown as the mean proportion of CD4+KJ1.26+ cells under each CFSE peak in uninfected (open bars) and
P. chabaudi-infected (filled bars) following immunization (bottom histogram) or in unimmunized controls (upper histogram). Data represent the mean
of 3 mice per group ±1 s.d. (*p  0.05, #p  0.005 uninfected and immunized versus P. chabaudi-infected and immunized).
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(b)Failure of heterologous antigen-specific T-cell
migration during malaria infection 
Optimal expansion of antigen-specific B cells requires their
cognate interaction with CD4+ T cells [52,53]; we therefore
examined the localization of OVA-specific CD4+ T cells fol-
lowing immunization. Five days after immunization of
uninfected mice, clonal expansion of antigen-specific T cells
was evident by immunohistochemistry, and these cells had
begun to migrate into B-cell follicles (Figure 9b). In
P. chabaudi-infected mice, however, not only were there
reduced numbers of OVA-specific T cells, but these cells were
almost completely excluded from B-cell follicles (see Figure
9b). Migration was quantified using laser-scanning cytome-
try [54,55]. As shown in Figure 9c, the average proportion of
OVA-specific CD4+ T cells in B-cell follicles was significantly
reduced in P. chabaudi-infected mice following immuniza-
tion compared with uninfected, immunized animals. This
demonstrates that in infected animals, CD4+ T cells fail to
migrate into follicles and therefore fail to interact with
antigen-specific B cells, both essential steps in the induction
of protective, adaptive immunity. Importantly, these failures
in T- and B-cell function are similar to situations in which
immune tolerance is induced [56-58], although few studies
have directly examined the interaction of T and B cells in vivo
during the course of infections. It should be noted that, in
contrast to the early inflammatory stage of the infection,
normal lymphoid architecture was apparent when these
defects in migration were observed, with clearly distinguish-
able, intact B- and T-cell areas (see Figure 9b).
To investigate whether the failure of T-cell migration into
follicles was simply due to a potential alteration in lym-
phoid architecture or chemokine gradients caused by
malaria infection, OVA-specific CD4+ T cells were initially
activated in vitro with bone-marrow-derived DCs and pRBCs
and then transferred into uninfected recipient mice. Expan-
sion of T cells stimulated in vitro with DCs cultured with
infected RBCs was reduced following transfer compared
with expansion of OVA-specific T cells activated in the pres-
ence of uninfected erythrocytes (Figure 9d), and these cells
also failed to migrate into B-cell follicles (data not shown). 
To address whether the defect in T-cell migration was due to
their activation in the context of parasite infection or to
modulation of DC function, highly purified DCs from the
spleens of malaria-infected animals or uninfected controls
were pulsed with OVA and transferred into naive BALB/c
recipient mice along with DO11.10 T cells labeled with the
fluorescent dye 5,6-carboxy-succinimidyl-fluorescein ester
(CFSE). Following transfer of OVA-pulsed DCs from unin-
fected mice, T cells divided efficiently, as seen by CFSE dilu-
tion (Figure 9e). In mice transferred with OVA-pulsed DCs
purified from the spleens of malaria-infected mice,
however, OVA-specific CD4+ T cells failed to divide to the
same extent (see Figure 9e), suggesting that DCs exposed to
malaria parasites are less capable of inducing effective T-cell
responses. Furthermore, DCs purified from in vitro culture
with pRBCs and pulsed with antigen were less able to
induce an optimal T-cell response upon transfer to unin-
fected recipients (data not shown). Thus the defect in T-cell
function and migration is primarily due to the modulation
of DC function by the malaria parasite, and not simply the
result of activation of T cells in the context of infection.
Discussion 
Several previous reports have suggested a generalized sup-
pression of immune responses during infection with Plas-
modium [2-10,12-21,24-34,59]. One possible mechanism
could be impairment of the function of DCs, a cell type that
is essential in the generation of the primary immune
responses [42]. But the significance of this observation for in
vivo studies, the implications for downstream immunologi-
cal function, and what (if any) parasite component mediated
this effect remained unclear. Here, we have shown that DCs
are modulated by the malaria parasite and are suppressed by
infection with P. chabaudi through the malarial pigment HZ.
Importantly, Plasmodium infection also causes a significant
defect in the induction of immune responses in vivo: expan-
sion and migration  of CD4+ T cells is greatly reduced, result-
ing in a consequent reduction in the interaction between
these T cells and B cells and in the help they can provide to
the B cells. Despite severely impaired T-cell migration and
effector function, early stimulation of antigen-specific CD4+
T cells is not affected by malaria infection, as T cells stimu-
lated in vitro and in vivo upregulate CD69, suggesting that,
despite suppression of DC function, there is sufficient
antigen presentation to induce initial T-cell activation. 
Although the observed defect in CD4+ T-cell function seems
to be directly related to inhibition of DCs, it has also been
suggested that optimal T-cell expansion and differentiation
requires the interaction of T and B cells [60]. Thus it may be
that the failure of DCs to activate properly and subsequently
induce T-cell migration into B-cell follicles also results in
the reduced expansion of CD4+ T cells observed here.
Nevertheless, the failure of optimal CD4+ T-cell expansion
and migration during infection clearly results in the abroga-
tion of B-cell expansion and a subsequent absence of anti-
body production at specific time-points during infection.
Thus, protective, systemic immunity against non-parasite
antigens, and presumably against parasite antigens, fails to
develop effectively. 
Although alterations in the architecture of the spleen during
infection with P. chabaudi have been described [61], these
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Figure 9 (see legend on the following page)
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0changes were less evident in our model, with intact B220+
B-cell follicles still clearly discernible by day 17 of infection
(see Figure 9b). Interestingly, infected mice immunized on
day 4 of infection (when lymphoid structure is already dis-
rupted [61]) were able to generate antibody responses, sug-
gesting that despite the breakdown in architecture, immune
priming is still normal in these mice. 
Our important finding that activated T cells fail to migrate
into follicles may in part be due to splenic alterations not
visualized in our immunohistochemical staining for B220,
or to alteration of chemokine gradients important for T-cell
migration in infected mice. To address these issues, we
transferred T cells that had been primed in vitro in the pres-
ence of malaria parasites into uninfected recipient mice
with normal lymphoid architecture. In addition, we immu-
nized naive, uninfected mice with OVA-loaded DCs which
had been cultured in vitro with infected erythrocytes. In all
of these situations we could separate the effect of parasites
upon DCs or T cells from the described disruption of lym-
phoid architecture (see Figure 9). In each case, T cells
primed in the presence of malaria parasites or T cells primed
by DCs exposed to infection failed to differentiate fully fol-
lowing transfer into uninfected recipients. Thus, alteration
of splenic architecture alone cannot account for our obser-
vations, suggesting that the failure in T-cell differentiation is
due to DC modulation.
Another possible explanation for the observed defect in the
induction of immunity could be through competition for
access to antigen between adoptively transferred OVA-
specific T cells and endogenous malarial antigen-specific T
cells. Thus, a large dose of blood-borne parasite antigens
could impede the induction of other (‘bystander’) immune
responses. But studies examining bystander responses in
other parasitic diseases (for example, [62-65]), as well as the
potent stimulatory capacity of mycobacteria-containing
complete Freunds’ adjuvant [66], suggest that such inhibi-
tion of immunity does not occur, despite potentially large
amounts of competing antigens. In our experiments, naive
OVA-specific CD4+ T cells activated in vitro and in vivo in the
presence of infected erythrocytes upregulated CD69 to the
same extent as T cells stimulated in uninfected controls, sug-
gesting that sufficient access to antigen was available to ini-
tiate T-cell signaling cascades (see Figures 7 and 8).
Furthermore, transfer of T cells activated in the presence of
infected erythrocytes, or transfer of purified DCs from
infected mice into uninfected recipients, transferred the
immunosuppressive phenotype, suggesting that the effect
cannot be ascribed to out-competition of the OVA-specific T
cells by malaria-specific cells (see Figures 8 and 9).
In search of a mechanistic explanation for these observa-
tions, we initially focused on analyzing the effect that para-
site proteins expressed on the erythrocyte membrane might
have on DC function. It is known that the development of
the parasites within erythrocytes is coupled with changes in
the host cells, including the host-cell plasma membranes
[67], and it is well established that parasites express ‘neo-
proteins’ on the host-cell surface, some of which are
reported to induce protective immunity [68-70]. Erythro-
cytes infected with the rodent-specific strain P. chabaudi
adhere to specific cell types by interacting with molecules
such as CD36 [71]; this is known as cytoadherence. Impor-
tantly, the interaction of P. falciparum-infected RBCs with
CD36 has been shown to mediate suppression of DC
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Figure 9
P. chabaudi infection causes reduced expansion of B cells and failure of CD4+ T-cell migration through modulation of DCs. (a) Uninfected (squares)
or P. chabaudi-infected (circles) BALB/c mice received OVA-specific CD4+ T cells and HEL-specific B cells 12 days after infection and were
immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number
of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of
3 similar experiments (*p  0.05, #p  0.005 uninfected and immunized versus P. chabaudi-infected immunized). (b) Five days after immunization,
spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26
followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are
representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are
expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in
identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26+ cells in
the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice
per group ±1 s.d. (*p  0.05 uninfected and immunized versus P. chabaudi-infected and immunized). (d) Bone-marrow-derived DCs were cultured
with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open
symbols). OVA-specific CD4+ T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro. T cells were isolated, washed and transferred
into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described
above. Results show the mean proportion of CD4+KJ1.26+ T cells and represent the mean of 3 mice per group ±1 s.d. (*p  0.05, RBC-cultured,
OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi-infected mice and
pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 x 105 DCs transferred into uninfected BALB/c mice along with
CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4+ cells was analyzed 5 days later, as described in Figure 8. function [72]. Examination of the P. chabaudi genome has
not, however, revealed any homologs of the P. falciparum
protein PfEMP1 [73], which is important in sequestration
[72]. Rather, a separate multigene family expressing surface
antigens was identified in P. chabaudi [73], which may have
a role in cytoadherence [74]. 
Another important difference between P. chabaudi  (the
rodent-specific strain used here) and the human-specific
strain  P. falciparum  is the presence of surface complexes,
known as knobs, in P. falciparum-infected erythrocytes,
which strengthen interactions between pRBCs and receptors
expressed on other cells [75]. P. chabaudi-infected pRBCs
have no evident knobs [76]. Thus, although P. falciparum
and P. chabaudi show specific differences in their mecha-
nisms of cytoadherence, pRBC-mediated DC suppression
might occur through interactions with membrane mol-
ecules, such as CD36. We therefore exposed DCs to erythro-
cyte ghosts from infected or uninfected erythrocytes, before
the LPS challenge. Ghosts isolated from pRBCs did not alter
the ability of DCs to respond to LPS treatment in vitro, sug-
gesting that parasite antigens expressed on the erythrocyte
plasma membranes do not induce the suppression previ-
ously described following contact with DCs in vitro. In
support of this finding is the observation that immuniza-
tion of mice with pRBC ghosts can induce protection from
parasite challenge [77], suggesting that protein structure is
maintained on erythrocyte ghosts and that ghosts, unlike
intact parasites, are not inherently immunosuppressive.
As fixed pRBCs suppressed the LPS-induced maturation of
DCs whereas pRBC membranes did not, HZ seemed to be a
good candidate to investigate when looking at the mecha-
nism of parasite-induced modulation of DC function. Previ-
ous reports have suggested that HZ impairs the
differentiation and functional capacity of human mono-
cytes and murine macrophages through the production of
IL-10 and/or the induction of peroxisome proliferator-
activated receptor- (PPAR-) [78-82]. The extrapolation of
these results to DCs remains somewhat controversial,
however, with other workers suggesting a proinflammatory
role for HZ, possibly via the Toll-like receptor-9 [83-86].
Our results suggest that intracellular parasite components,
including HZ, do indeed suppress DC maturation and func-
tion in vitro. The exact mechanism involved in this suppres-
sion remains undefined, although it is interesting that
phagocytosis of HZ has been found to increase degradation
of protein kinase C [87]. Thus, degradation of key intracel-
lular signaling molecules may be one mechanism by which
Plasmodium parasites suppress DC function. Together, these
results suggest that in contrast to P. falciparum, intracellular
HZ rather than P. chabaudi-derived membrane-expressed
proteins is responsible for the suppression of APC function. 
The results presented here clearly demonstrate that DC func-
tion is dynamically modulated in vitro and in vivo by asexual
blood-stage malaria parasites. These findings support previ-
ous studies with P. falciparum-infected erythrocytes and
human monocyte-derived DCs [42] as well as studies in
vitro and in vivo of Plasmodium yoelii with murine DCs [88].
Other studies suggest, however, that P. chabaudi schizonts
activate DCs in vitro [40]. Similarly, in previous studies
[45,89], DCs isolated from P. yoelii-infected mice during
peak parasitemia were found to be activated and to effi-
ciently process and present antigen to naive T cells. In the
present study, DCs exposed to trophozoite-infected erythro-
cytes show impaired maturation in response to stimulation,
indicating that it is not only different parasites (P. yoelii
versus P. chabaudi) but also different stages (trophozoites
versus schizonts) that have different effects on DC function.
Interestingly, the observed differences in the ability of
pRBCs to stimulate DC maturation may arise through con-
tamination of parasite material with mycoplasmas, which
are known to contain potent Toll-like receptor (TLR) ligands
that efficiently activate DCs [90-92]. 
It has recently been suggested that, during malaria infection
in vivo, DCs are activated during early infection and then
show TLR tolerance later in infection, becoming unrespon-
sive to LPS stimulation [93]. We believe this not to be the
case with P. chabaudi, however, because we see no evidence
of direct maturation of the DCs by the parasite (see Figure
2). In addition, activated DCs show an increased ability to
stimulate T-cell proliferation and cytokine production [36],
neither of which were observed in the T-cell assays in the
current study. Rather, we suggest that the transient increased
expression of activation markers on DCs ex vivo reflects the
high concentrations of pro-inflammatory cytokines caused
by the early stage of infection [94]. In support of this, a
recent report described that DCs activated through inflam-
matory cytokines without pathogenic stimulation upregu-
lated markers of activation but were unable to drive CD4+
T-cell differentiation [95].
The ability of DCs to interact with CD40L on T cells in vivo
has also been used to explain the differences between in vivo
and in vitro studies [45]. Interestingly, in our study we could
not rescue DC maturation when pRBC-treated DCs were
stimulated with CD40L-transfected fibroblasts, also suggest-
ing that TLR tolerance (the refractory state of DCs to a
second stimulation with a TLR ligand) is not involved in the
failure of DCs to respond to stimulation. This suggests that
the effects that P. chabaudi-infected erythrocytes exert on DC
function  in vitro might be more profound than those
induced by P. yoelii infection. Whether these changes to the
CD11c+ population as a whole reflect changes in individual
subsets of DCs awaits further investigation. Importantly, we
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inhibition of DC function rather than to suppression of T
cells or breakdown of splenic architecture, as transfer of T
cells activated in the context of parasites in vitro or of DCs
from infected mice was sufficient to prevent subsequent
T-cell differentiation in uninfected recipients (see Figure 9).
The results presented here demonstrate, for the first time,
that suppression of immunity associated with P. chabaudi
affects multiple populations of cells essential for develop-
ment of immunity. DC function is impaired during parasite
infection, as a result of ingestion of HZ, and although CD4+
T cells specific for a non-parasite antigen become activated
following immunization, they fail to expand clonally as effi-
ciently as in uninfected controls. Crucially, these T cells sub-
sequently show a defect in their ability to migrate into B-cell
areas and, consequently, fail to provide effective help for
B-cell expansion and antibody production. These results
demonstrate an overall defect in priming of heterologous
immune responses during Plasmodium infection and
provide an explanation for increased secondary infections
and the reduced efficacy of vaccines in areas where malaria
is endemic.
Materials and methods 
Animals and challenge infections 
Female BALB/c mice were purchased from Harlan Olac
(Bicester, UK). DO11.10 mice, with CD4+ T cells specific for
the OVA323-339 peptide in the context of the MHC class II
molecule I-Ad recognized by the KJ1.26 clonotypic antibody
[96] were obtained originally from N. Lycke, University of
Göteborg, Sweden. MD4 mice containing HEL-specific B
cells [51] were backcrossed onto the BALB/c background.
All mice were maintained at Biological Services, University
of Glasgow, under specific pathogen-free conditions and
first used between 6 and 8 weeks of age in accordance with
local and UK Home Office regulations. 
To initiate a malaria infection, mice were inoculated with
1x  1 0 6 P. chabaudi AS-infected erythrocytes intra-peritoneally.
Parasitemia was monitored by thin blood smears stained
with Giemsa’s stain. Peak parasitemia occurred at 5-6 days
post-infection, after which time parasite levels declined and
remained at low but usually detectable levels for the
remainder of the experiments (see Figure 1a), as previously
described [97]. Infected mice were held in a reverse
light/dark cycle so that parasites harvested at 08:00 h were
at the late trophozoite stage. For studies in vitro, blood was
collected when parasitemia was 30-40%. Infected blood was
recovered into heparin (10 IU/ml) by cardiac puncture and
diluted in phosphate-buffered saline (PBS; Invitrogen,
Paisley, UK) to the required concentration of pRBCs. 
At various times following malaria infection, mice were
immunized intravenously with 500 g OVA (Sigma-
Aldrich, Poole, UK), or a conjugate of OVA and HEL
(Biozyme, Gwent, UK) [50], along with 50 ng LPS (from
Salmonella equi-abortus; Sigma-Aldrich).
Preparation of bone-marrow DCs  
DCs were prepared from bone marrow as previously
described [98]. Cell suspensions were obtained from femurs
and tibias of female BALB/c mice. The bone-marrow cell
concentration was adjusted to 5 x 105 cells/ml and cultured
in six-well plates (Corning Costar, New York, USA) in
complete RPMI (cRPMI: RPMI 1640 supplemented with
L-glutamine (2 mM), penicillin (100 U/ml), streptomycin
(100 g/ml) (all from Invitrogen) and 10% fetal calf serum
(FCS; Labtech International, Ringmer, UK) containing 10%
of culture supernatant from X63 myeloma cells transfected
with mouse granulocyte-macrophage colony stimulating
factor (GM-CSF) cDNA. Fresh medium was added to the
cell cultures every 3 days. On day 6, DCs were harvested and
cultured at the required concentration for each individual
experimental procedure, as described below. This technique
generated a large number of CD11c+ DCs largely free from
granulocyte and monocyte contamination, as previously
described [98].
In vitro culture of DCs with fixed infected or
uninfected erythrocytes 
Blood from P. chabaudi AS-infected mice was washed twice
in PBS before being resuspended in cRPMI for addition to
DCs. For fixation, infected blood was washed three times in
PBS and resuspended in 0.5% paraformaldehyde for 30 min
at 4°C. Fixed erythrocytes were then washed in PBS, resus-
pended in 0.06% Gly-Gly (Sigma-Aldrich) for 5 min at 4°C
and washed twice more in PBS before being resuspended in
cRPMI for addition to DC. After 24 h culture, DCs were stim-
ulated with 1 g/ml LPS and the expression of cell-surface
molecules was analyzed 18 h later by flow cytometry. To
confirm complete fixation, we showed that 2 x 107 fixed,
infected erythrocytes could not establish infection when
injected intra-peritoneally into a female BALB/c mouse. 
In vitro culture of CD40L-transfected fibroblasts
with DCs 
The cell lines 3T3-CD40L and 3T3-SAMEN [46] were kind
gifts from P. Hwu (NCI, Bethesda, USA). Cells were grown
in cRPMI in T75 tissue culture flasks (Helena Biosciences,
Gateshead, UK) and, when confluent, harvested and distrib-
uted in six-well plates at 2.5 x 105 cells/ml of cRPMI. Bone
marrow-derived DCs were cultured with infected or unin-
fected erythrocytes at a ratio of 1:100. After 24 h, DCs were
harvested, resuspended at 1 x 106 cells/ml and cultured in a
1:1 ratio with either 3T3-CD40L or 3T3-SAMEN cells for a
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lyzed by flow cytometry and culture supernatants collected
for IL-12 cytokine analysis.
T-cell stimulation in vitro
Bone-marrow DCs were centrifuged at 450 x g, resuspended
at 1 x 106 cells/ml and 500 l aliquots were distributed into
24-well tissue culture plates (Corning Costar) with pRBCs
or RBCs. After 24 h incubation at 37°C in 5% CO2, DCs
were antigen-loaded for 6 h with 5 mg/ml OVA (Worthing-
ton Biochemical, Freehold, USA). OVA-specific T cells were
isolated from the mesenteric and peripheral lymph nodes of
DO11.10 transgenic mice [96] on the SCID background and
cultured at a 1:1 ratio with DCs. T-cell proliferation was
assessed after 48, 72, 96 and 120 h of culture and assessed
by incorporation of [3H]thymidine (0.5 Ci/well) for the
last 24 h of culture. Cells were harvested using a Betaplate
96-well harvester (Wallac Oy, Turku, Finland) and
[3H]thymidine incorporation measured on a Betaplate
liquid scintillation counter (Wallac).
Cytokine assay 
For the detection of IL-12 (p40 and p70) and IL-10,
OptEIATM enzyme-linked immunosorbent assay (ELISA)
kits (Becton Dickinson, Oxford, UK) were used according to
the manufacturer’s instructions. For T-cell cytokines, Mouse
Th1/Th2 6-Plex kit (Biosource, Nivelles, Belgium) was used
according to the manufacturer’s instructions. For analysis of
cytokine production ex vivo, single-cell suspensions of
spleen cells were prepared by rubbing through Nitex mesh
(Cadisch & Sons, London, UK) in RPMI 1640 medium.
After washing, cells were resuspended at 4 x 106 cells/ml in
cRPMI, either alone or with 1 mg/ml OVA or 5 g/ml con-
canavalin A (ConA; Sigma-Aldrich) and supernatants
sampled after 48 h. These were stored at -20°C until analy-
sis by standard sandwich ELISA protocol (antibodies used:
for IFN- capture, R4-6A2; for IFN- detection, XMG1.2; for
IL-5 capture, TRKF5; for IL-5 detection, TRKF4; Pharmingen,
Oxford, UK) and the levels of cytokine in supernatants cal-
culated by comparison with recombinant cytokine stan-
dards (R & D Systems, Abingdon, UK).
Flow cytometry 
Aliquots of 1 x 106 cells in 12 x 75 mm polystyrene tubes
(Falcon BD, Oxford, UK) were resuspended in 100 l FACS
buffer (PBS, 2% FCS and 0.05% NaN3) containing Fc Block
(2.4G2 hybridoma supernatant) as well as the appropriate
combinations of the following antibodies: anti-CD4-PerCP
(clone RM4-5), anti-CD11c-PE (clone HL3), anti-CD40-
FITC (clone 3/23), anti-CD69-PE (clone H1.2F3), anti-
CD80-FITC (clone 16-10A1), anti-CD86-FITC (clone GL1),
anti-MHC-II (clone 2G9), anti-B220-PE (clone RA3-6B2),
PE-hamster IgG isotype control, FITC-rat IgG2a,  isotype
control and FITC-hamster IgG1,  isotype control (anti-TNP)
(all Pharmingen), biotinylated KJ1.26 antibody or biotiny-
lated HEL. Biotinylated antibodies were detected by incuba-
tion with fluorochrome-conjugated streptavidin (Pharmingen).
After washing, samples were analyzed using a FACSCalibur
flow cytometer equipped with a 488 nm argon laser and a
635 nm red diode laser and analyzed using CellQuest soft-
ware (both BD BioSciences, Oxford, UK).
Preparation of erythrocyte ghosts from infected and
uninfected mouse blood 
Ghosts from infected and uninfected erythrocytes were gen-
erated as previously described [67]. Briefly, blood was col-
lected into heparin by cardiac puncture and washed three
times in PBS. Infected and uninfected erythrocytes were
concentrated in PBS supplemented with 113 mM glucose
(Sigma-Aldrich) and 3% FCS. Infected erythrocytes were
incubated in an equal volume of glycerol buffer (10% glyc-
erol (Sigma-Aldrich) supplemented with 5% FCS in PBS)
for 1 h at 4°C. Parasites and ghosts were separated in a con-
tinuous Percoll (Amersham Biosciences, Little Chalfont,
UK) gradient (: 1.02-1.10 g/cm3) in intracellular medium
buffer (IM: 20 mM NaCl, 120 mM KCl, 1 mM MgCl2,
10 mM glucose, 5 mM Hepes pH 6.7) by centrifugation at
5,000 x g for 30 min. Ghosts were then washed in IM buffer
and layered on a two-step Percoll gradient (: 1.01+1.02
g/cm3) to separate them from ghosts that might still contain
parasites. Ghosts from uninfected erythrocytes were
obtained by adding a 40-fold volume of phosphate buffer
(5 mM NaH2PO4/Na2HPO4, 1 mM PMSF, 0.01% azide, pH
8.5). The suspension was centrifuged at 32,000 x g for
30 min. Ghosts from infected and uninfected erythrocytes
were then washed three times in PBS before being resus-
pended in cRPMI for addition to DCs at a ratio of 100:1.
Hemozoin preparation 
HZ was isolated from supernatants obtained from cultures
of  P. falciparum gametocytes, kindly provided by Lisa
Ranford-Cartwright, (Division of Infection and Immunity,
University of Glasgow, UK). Endotoxin-free buffers and
solutions were used throughout. Supernatants were cen-
trifuged for 20 min at 450 x g. The pellet was washed three
times in 2% SLS and resuspended in 6 M guanidine HCl.
Following 5-7 washes in PBS, the pellet was resuspended in
PBS and sonicated for 90 min using Soniprep 150 (Sanyo
Scientific, Bensenville, USA) at an amplitude of 5-8 m to
minimize aggregation and maintain the HZ in suspension.
Total heme content was determined as previously described
[99] by depolymerizing heme polymer in 1 ml of 20 mM
NaOH and 2% SDS, incubating the suspension at room
temperature for 2 h and then reading the optical density at
400 nm using a UV-visible Helios spectrophotometer
(Thermo Spectronic, Cambridge, UK). DCs were pulsed
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seen when DCs were cultured at a 1:100 ratio with pRBCs.
Assessment of antigen-specific antibody responses 
Peripheral blood was collected and the plasma was sepa-
rated by centrifugation at 450 x g for 10 min and stored at
-20°C until analysis. OVA-specific IgG was measured by
standard sandwich ELISA using a peroxidase-conjugated
anti-mouse total IgG (Sigma-Aldrich).
Adoptive transfer of antigen-specific lymphocytes 
Lymph nodes and spleens were homogenized and the result-
ing cell suspensions washed twice by centrifugation at 400 x
g for 5 min and resuspended in RPMI. The proportions of
antigen-specific T cells were evaluated by flow cytometry,
and syngeneic recipients received 3 x 106 antigen-specific
cells. In some experiments, cells were labeled with the fluo-
rescent dye CFSE (Molecular Probes, Oregon, USA) immedi-
ately before use [100]. The level of CFSE in cells was
analyzed by flow cytometry and expressed as the mean pro-
portion of antigen-specific T cells under each CFSE peak.
Immunohistochemistry 
Spleens were frozen in liquid nitrogen in OCT embedding
medium (Miles, Elkart, USA) in cryomoulds (Miles) and
stored at -70°C. Tissue sections (8 m) were cut on a cryo-
stat (ThermoShandon, Cheshire, UK) and stored at -20°C.
Sections were blocked and stained as previously described
[55], using B220-FITC to stain B-cell areas and biotinylated-
KJ1.26 to detect OVA-specific DO11.10 cells, and visualized
using Streptavidin-Alexa Fluor 647 (Molecular Probes). All
photographs were taken at 20x magnification. 
To visualize HZ deposition in DCs, cells were photographed
using an Axiovert S-100 Zeiss microscope using a 63x oil-
immersion lens by normal bright-field imaging. To image
HZ in splenic DC, 8 m sections were cut as described
above and stained with biotinylated-CD11c followed by
Streptavidin-HRP and finally tyramide-488 (PerkinElmer,
Boston, USA). Images were then taken of bright-field and
green fluorescence and the images merged by inverting and
then false coloring the bright-field image such that
deposited HZ appeared red and CD11c appeared green. 
Laser-scanning cytometry 
Sections were stained as described above. Sections were
then scanned on a laser-scanning cytometer equipped with
argon, helium, neon, and ultraviolet lasers (Compucyte,
Cambridge, USA) and visualized with the Openlab imaging
system (Improvision, Coventry, UK). The localization of
transgenic T cells and B-cell follicles were plotted. Using
these tissue maps the number of transgenic T cells in
defined gates was calculated for three gates in periarteriolar
lymphoid sheath (PALS) and three B-cell follicle gates per
section. Data are plotted as the mean proportion of trans-
genic T cells in each gate relative to the number of trans-
genic T cells in the entire section and are the mean of
triplicate readings from three mice per group.
Isolation of DCs from spleen 
Spleens were excised and single-cell suspensions obtained
as described above. In some experiments, cells were stimu-
lated with 1 g/ml LPS for 18 h before analysis by flow
cytometry. To obtain purified DCs from spleens of mice,
single-cell suspensions were labeled using a CD11c isola-
tion kit (Miltenyi Biotec, Bisley, UK) according to the manu-
facturer’s instructions. DCs were then purified using two MS
magnetic columns (Miltenyi Biotec) and found to be 85-
95% pure by flow cytometric analysis.
Statistical analysis 
Results are expressed as mean ± standard error or standard
deviation as indicated. Significance was determined by one-
way ANOVA in conjunction with the Tukey test using Minitab.
A p-value of less than 0.05 was considered significant.
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